Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeons for Both Procedures.

Teh J, Koschel S, Thangasamy I, Sathianathen N, Murphy DG, Eapen R.

Eur Urol. 2020 Feb;77(2):285-286. doi: 10.1016/j.eururo.2019.08.027. Epub 2019 Aug 31. No abstract available.

PMID:
31477345
2.

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.

Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL 3rd, Herlemann A, Carroll PR, Cooperberg MR.

JCO Clin Cancer Inform. 2019 Jul;3:1-8. doi: 10.1200/CCI.18.00084.

3.

Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides.

Charoenpattarapreeda J, Tan YS, Iegre J, Walsh SJ, Fowler E, Eapen RS, Wu Y, Sore HF, Verma CS, Itzhaki L, Spring DR.

Chem Commun (Camb). 2019 Jul 14;55(55):7914-7917. doi: 10.1039/c9cc04022f. Epub 2019 Jun 21.

PMID:
31225847
4.

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.

Eapen RS, Nzenza TC, Murphy DG, Hofman MS, Cooperberg M, Lawrentschuk N.

World J Urol. 2019 Jul;37(7):1255-1261. doi: 10.1007/s00345-018-2524-z. Epub 2018 Oct 29. Review.

PMID:
30374609
5.

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.

Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):117-124. doi: 10.1038/s41391-018-0084-3. Epub 2018 Aug 31.

PMID:
30171230
6.

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier.

Herlemann A, Washington SL 3rd, Eapen RS, Cooperberg MR.

Urol Clin North Am. 2017 Nov;44(4):547-555. doi: 10.1016/j.ucl.2017.07.003. Review.

PMID:
29107271
7.

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.

Eapen RS, Herlemann A, Washington SL 3rd, Cooperberg MR.

Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383. Review.

PMID:
28221220
8.

Images in Anesthesiology: Laryngeal Cleft.

Eapen RJ, Taicher BM, Benner E, Machovec K.

Anesthesiology. 2017 Feb;126(2):325. doi: 10.1097/ALN.0000000000001337. No abstract available.

PMID:
28098610
9.

Water-Bridge Mediates Recognition of mRNA Cap in eIF4E.

Lama D, Pradhan MR, Brown CJ, Eapen RS, Joseph TL, Kwoh CK, Lane DP, Verma CS.

Structure. 2017 Jan 3;25(1):188-194. doi: 10.1016/j.str.2016.11.006. Epub 2016 Dec 1.

10.

Review of the epidemiology of overactive bladder.

Eapen RS, Radomski SB.

Res Rep Urol. 2016 Jun 6;8:71-6. doi: 10.2147/RRU.S102441. eCollection 2016. Review.

11.

Practice patterns in supraglottoplasty and perioperative care.

Ramprasad VH, Ryan MA, Farjat AE, Eapen RJ, Raynor EM.

Int J Pediatr Otorhinolaryngol. 2016 Jul;86:118-23. doi: 10.1016/j.ijporl.2016.04.039. Epub 2016 May 3.

12.

Gender differences in overactive bladder.

Eapen RS, Radomski SB.

Can J Urol. 2016 Feb;23(Suppl 1):2-9. Review.

13.

Nasopharyngeal Masses Arising from Embryologic Remnants of the Clivus: A Case Series.

Sajisevi M, Hoang JK, Eapen R, Jang DW.

J Neurol Surg Rep. 2015 Nov;76(2):e253-7. doi: 10.1055/s-0035-1564603. Epub 2015 Oct 25.

14.

Influence of electronic medical record implementation on provider retirement at a major academic medical centre.

Crowson MG, Vail C, Eapen RJ.

J Eval Clin Pract. 2016 Apr;22(2):222-6. doi: 10.1111/jep.12458. Epub 2015 Sep 22.

PMID:
26395432
15.

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.

Eapen R, Liew MS, Tafreshi A, Papa N, Lawrentschuk N, Azad A, Davis ID, Bolton D, Sengupta S.

ANZ J Surg. 2015 Jul-Aug;85(7-8):535-9. doi: 10.1111/ans.12772. Epub 2014 Jul 14.

PMID:
25040795
16.

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.

Liew MS, Azad A, Tafreshi A, Eapen R, Bolton D, Davis ID, Sengupta S.

BJU Int. 2013 Nov;112 Suppl 2:74-82. doi: 10.1111/bju.12384.

17.

Bilateral cochlear implantation: current concepts, indications, and results.

Basura GJ, Eapen R, Buchman CA.

Laryngoscope. 2009 Dec;119(12):2395-401. doi: 10.1002/lary.20751. Review.

PMID:
19894280
18.

Bilateral cochlear implantation: current concepts.

Eapen RJ, Buchman CA.

Curr Opin Otolaryngol Head Neck Surg. 2009 Oct;17(5):351-5. doi: 10.1097/MOO.0b013e3283301702. Review.

PMID:
19606037
19.

Hearing-in-noise benefits after bilateral simultaneous cochlear implantation continue to improve 4 years after implantation.

Eapen RJ, Buss E, Adunka MC, Pillsbury HC 3rd, Buchman CA.

Otol Neurotol. 2009 Feb;30(2):153-9.

20.

The development of frequency weighting for speech in children with a history of otitis media with effusion.

Eapen RJ, Buss E, Grose JH, Drake AF, Dev M, Hall JW.

Ear Hear. 2008 Oct;29(5):718-24. doi: 10.1097/AUD.0b013e31817a98cb. Erratum in: Ear Hear. 2008 Dec;29(6):979.

Supplemental Content

Support Center